ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,051.25
-0.54%
US Tech 100
21,169.20
-0.13%
Dow Jones
43,914.12
-0.53%
Brent Oil
73.21
0.00%
Bitcoin
100,115.80
0.06%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Abionyx Pharma (ABNX) Quote

Abionyx Pharma

Abionyx Pharma (ABNX)

EU
1.28
-0.014
(-1.08%)
Closed December 12 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.28
Bid
1.274
Ask
1.324
Volume
67,126
1.272 Day's Range 1.326
0.91 52 Week Range 1.50
Market Cap
41.548M
Previous Close
1.294
Open
1.272
Last Trade
107
@
1.28
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
48,941
Shares Outstanding
32,459,012
Dividend Yield
-
PE Ratio
-11.81
Earnings Per Share (EPS)
-0.11
Revenue
4.74M
Net Profit
-3.52M

About Abionyx Pharma

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.abionyx.com
Headquarters
Balma, Haute-garonne, Fra
Founded
-
Abionyx Pharma is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ABNX. The last closing price for Abionyx Pharma was 1.29 €. Over the last year, Abionyx Pharma shares have traded in a share price range of 0.91 € to 1.50 €.

Abionyx Pharma currently has 32,459,012 shares outstanding. The market capitalization of Abionyx Pharma is 42.00 € million. Abionyx Pharma has a price to earnings ratio (PE ratio) of -11.81.

Ask ADVFN Intelligence (AI)

ABNX Latest News

More News

ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market:...

December 05 2024
Business Wire

ABIONYX Pharma annonce l’approbation de l’ensemble des résolutions soumises au vote lors de son Assemblée Générale Mixte du 28 novembre 2024

Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – éligible PEA PME), société de biotechnologie de nouvelle génération dédiée à la découverte et au développement de thérapies innovantes...

November 29 2024
Business Wire

ABIONYX Pharma Provides an Update on Its Business and Cash Position for the Third Quarter of 2024

Consolidated revenue of €3.4m at the end of September 2024 Cash position of €4.1m before receipt of IRIS Pharma’s CIR (€610k) as of September 30, 2024 Live broadcast of the General Meeting on...

November 14 2024
Business Wire

ABIONYX Pharma Announces the Main Resolutions Proposed at the Next Combined General Meeting on November 28, 2024, and the Availability of Related Documents

Proposed appointment of Jean-Gérard Galvez, Luc Demarre and Caroline DeSurmont as directors Proposed financial delegations necessary for the Company's development Proposed amendments to the...

November 07 2024
Business Wire

ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market:...

November 05 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0020.1564945226921.2781.3341.206302761.29134247DE
4-0.07-5.185185185191.351.3641.2401741.3010751DE
120.032.41.251.51.128489411.29683691DE
260.010.7874015748031.271.51.11471771.29481983DE
52-0.11-7.913669064751.391.50.91506771.22652351DE
156-1.48-53.62318840582.763.570.911043071.84815411DE
2600.919254.5706371190.3613.570.322456581.41137087DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ATOAtos SE
0.0026 €
(52.94%)
6B
NICBSNicox SA
0.0179 €
(47.93%)
240.74k
FIPPFipp
0.145 €
(28.32%)
70
ALPRIPrismaflex International
6.70 €
(27.62%)
7.16k
MLSMLSmalto
0.016 €
(23.08%)
2.59k
EXNExclusive Networks SA
18.84 €
(-22.15%)
14.35k
MLACTActivium Group
1.12 €
(-18.84%)
130
MLEFAEduformAction
0.41 €
(-16.33%)
8.16k
MLVERVerney Carron
5.25 €
(-16.00%)
600
ALBOOBOOSTHEAT
0.1715 €
(-14.25%)
12.41k
ATOAtos SE
0.0026 €
(52.94%)
6B
OPTICrescent NV
0.0102 €
(-7.27%)
449.67M
ALCYBCybergun
0.0001 €
(0.00%)
37.85M
BCPBanco Comercial Portugues SA
0.4407 €
(0.23%)
25.96M
ALTDTonner Drones
0.0118 €
(-3.28%)
17.36M

Discussion

View Full Feed
Whalatane Whalatane 38 seconds ago
Well this is semi OT ...but since you read balance sheets ...RGTI is losing $ just like AMRN but unlike AMRN ....will need $ from somewhere next yr
You also have end of year tax loss selling in AMRN vs those with huge gains in RGTI.... who may be waiting to take profits ( at a lower tax ra
AMRN RGTI
mascale mascale 47 seconds ago
So freecs post, "No." finds zero supportive veracity: Especially from the combined information from Hiru management and from OTCMG data posted. There is nothing wishful posted in the sources. There is mutually supportive information posted in the sources: Literacy!
HIRU
DMC8 DMC8 1 minute ago
Posted in Cardiology
December 12, 2024
https://gpvoice.com.au/index.php/2024/12/12/icosapent-ethyl-for-hypertriglyceridaemia-who-is-eligible/
AMRN
fuagf fuagf 1 minute ago
brooklyn13, And this is what happens when factual comment is unfairly said to be anti-semetic ..
https://www.nytimes.com/2024/12/12/us/university-of-michigan-dei-administrator-antisemitism.html

As for your post, for the zillionth time no one here has ever conflated Israel
Lime Time Lime Time 2 minutes ago
It's very disturbing, borderline insanity. I think all Sharp shells will do good.

Trash my CEO on one board and congratulate my CEO on another board, that's being called out as a fraud.

It's funny.
WNFT
carlson carlson 4 minutes ago
Thanks!
NBRI
Jnixx Jnixx 4 minutes ago
Read my post da
HMBL
hvp hvp 4 minutes ago
I believe that is definitely the same Mark. And I would definitely put him in the Chandra pimp category. People thought he knew what he was talking about and lost a lot of money.
ENZC
firebag1 firebag1 4 minutes ago
sowin Fud
theyll say its a dud
slip in the mud
dont believe them bud
HMBL
Snake River Dog Snake River Dog 5 minutes ago
Big Move Coming!! Under The Radar!! Time Will Tell!!
NAFS
Drugdoctor Drugdoctor 5 minutes ago
re"It's good to be a King" >>
[yt]2SF1iLXSQto[/yt]
GVSI
firebag1 firebag1 6 minutes ago
well you cant say it definitively now can you??
i knew the old rs card would show up lol i wonder why!??
but thanks i will buy dips too
HMBL
STL Stock STL Stock 6 minutes ago
My thoughts exactly. RS is pure speculation until it's not. We don't know. Nobody knows. It's just an attempt to sow FUD. Meanwhile the SP rises and volume is ridiculous.
HMBL
Craig305 Craig305 7 minutes ago
I thought Alessi got out of the shell game when the new OTC rules went into effect. Is he back in the game now?
SuperLogisticsMan SuperLogisticsMan 8 minutes ago
Thanks, UAS-Pro. I was unaware of this news. Looking forward to it.
CYBL
Jnixx Jnixx 8 minutes ago
I just said there will be an r/s…
HMBL
x993231 x993231 9 minutes ago
That they did.  Not sure, but I think Lebby was caught off guard, the fact that Yevs stepped up in minutes speakes volumes.  He hadsa record of M&A ing companies in a period of months.

X. We are more than golden, give them a little while to format a plan forward.   Kind of like, well
LWLG
firebag1 firebag1 9 minutes ago
i think Stevie Wonder said this once

Roses are black
violets are black
everything is black
im fcking blind

lol
HMBL
Drugdoctor Drugdoctor 10 minutes ago
Yep, despicable poster, bashing some Sharp shells, pumping the others he is invested in, and trying to act like he has some superior knowledge of the facts surrounding the stocks. LMAO
WNFT
willyw willyw 10 minutes ago
There's no fool like an old fool. 🙂 I am somewhat comfortable with the current RSV presentation, I'm kinda in hold mode. Hell, I've been in hold mode since Enanta started (and later discontinued a 2nd HBV candidate, then a covid candidate). I rationalize that I'm lowering my average stock s
ENTA
Snake River Dog Snake River Dog 10 minutes ago
NAFS .0001 Under The Radar!! Big Move Coming!! Keep a close eye on this one!! Time Will Tell!!
NAFS
Backstabbed Backstabbed 10 minutes ago
Good for you. You must be making a killing then.
BURU
BigBadWolf BigBadWolf 10 minutes ago
Hell(o) that’s a given con una $latina y vale cada centavo muchas memos dolares
LATINA
layton layton 11 minutes ago
Bingo.
HMBL
Carjockey2 Carjockey2 11 minutes ago
Hi Tenkay

https://x.com/randylus/status/1867365410997514289?t=8O20BL4pektp-5KLCfPtZA&s=19
HMBL

Your Recent History

EU
ABNX
Abionyx Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved